BCF | NGT (n=276) | IGR (n=323) | DM (n=315) | ||||
---|---|---|---|---|---|---|---|
TyG | r | P | r | P | r | P | |
Late-phase BCF indices | |||||||
I120/I0ratio DI | -0.180a | 0.023 | -0.256e | <0.001 | -0.283k | <0.001 | |
CP120/CP0ratio DI | -0.233b | 0.003 | -0.369f | <0.001 | -0.325k | <0.001 | |
△I120/△G120 ratio DI | 0.012c | 0.878 | 0.012g; | 0.866 | -0.192l | 0.005 | |
△CP120/△G120ratio DI | 0.027c | 0.737 | -0.032h | 0.4658 | -0.181m | 0.009 | |
CIR120x10-2 DI | -0.045d | 0.577 | -0.216i | 0.002 | -0.374n | <0.001 | |
Stumvoll second phase x10-2 DI | -0.166d | 0.037 | -0.254J | <0.001 | -0.253o | <0.001 |
A, DBP ajusted; b, SBP, DBP, HbA1C ajusted; c, HDL ajusted; d, Gender, SBP, DBP, TC, HbA1C ajusted; e, Age ajusted; f, Age, HbA1C ajusted; g, TC ajusted; h, HbA1c ajusted; i, Age, HbA1C, HDL, FCP, FINS ajusted; j, i+TC ajusted; k, Gender,Age, DBP, HbA1C, HDL FCP, FINS ajusted; l, Gender, DBP, HbA1C, HDL ajusted; m, Age,. SBP, DBP, HbA1C, HDL, FCP, FINS ajusted; n, Gender, HbA1C, HDL ajusted; o, Age, Gender, TC, HbA1C, FCP, FINS ajusted.